Fungicides used in agriculture have been linked to an increase in resistance to antifungal drugs in both humans and animals.
Fungal infections are on the rise, and two UC Davis infectious disease experts, Dr. George Thompson and Dr. Angel Desai, are sounding the alarm. In a recent commentary published in the New England Journal of Medicine, they warn that new agricultural pesticides designed to kill harmful fungi might be making it harder to treat dangerous fungal infections in people and animals.
Fungi already cause serious health and economic problems around the world. While antifungal agents are essential tools in both medicine and agriculture, overuse or poorly coordinated development of these compounds could lead to fungi evolving resistance. This means that life-saving treatments for humans might stop working.
Thompson and Desai are urging the global community to adopt a “One Health” approach to developing, testing and using agents to fight pathogens like fungi and bacteria.
“Antimicrobial resistant pathogens are a constant reminder for us to use agents judiciously,” Thompson said. “We have learned that the widespread use of antibiotics for livestock resulted in the rapid development of resistance to antibacterials. We have similar concerns regarding the use of antifungals in the environment.”
Thompson is the article’s lead author. He is a professor at the UC Davis School of Medicine in the Department of Internal Medicine, Division of Infectious Diseases, and the Department of Medical Microbiology and Immunology.
A One Health approach proposes a more holistic view to health. It emphasizes how changes in one area — like human activity, animal health, or the environment — can have ripple effects across all three.
About antifungal resistance
Changes in the climate and the wind patterns can help spread pathogens like fungi. Also, human travelers, migrating animals, and the movement of contaminated items can carry pathogens to new areas.
In the last few decades, there has been a rapid increase in fungus types that cause severe infections in humans. One example of a difficult-to-treat fungus is Candida auris (C. auris).
“Fungi have similar cellular machinery to that of humans. This is why medications that kill fungi like C. auris often have side effects for people. With few antifungals to choose from during clinical care, preventing resistance is of paramount importance,” Thompson explained.
Coordinated pesticide development and use
Resistance to treatments is highly linked to the amount of each agent used, the authors wrote. They called for coordinated global regulation to slow the development of resistance to new antimicrobial agents.
“There is a need for a shared antimicrobial approval process that includes a thorough assessment of potential impacts on the environment and human and animal health. This is especially true before any new large-scale environmental and agricultural pesticide use,” Desai said. She is an associate professor in the Department of Internal Medicine.
Their report also noted the foundation of The Interagency Drug and Pesticide Resistance and Efficacy Workgroup, a new entity under The U.S. Environmental Protection Agency. It is tasked with providing input on upcoming compounds proposed for registration, including potential effects on medical practice. The authors said similar efforts are needed on a global scale.
They noted that shared decision-making among national and global regulatory agencies would be cost-effective. It might help avoid the more expensive and riskier prospects of the rapid spread of resistant pathogens.
Reference: “Addressing Antifungal Drug Resistance — A “One Health–One World” Challenge” by George R. ThompsonIII and Angel N. Desai, 11 June 2025, New England Journal of Medicine.
DOI: 10.1056/NEJMp2416548
News
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
